Your browser doesn't support javascript.
loading
Flow cytometric false myeloperoxidase-positive childhood B-lineage acute lymphoblastic leukemia.
Savasan, Süreyya; Buck, Steven; Gadgeel, Manisha; Gabali, Ali.
Afiliação
  • Savasan S; Division of Hematology/Oncology, Carmen and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan.
  • Buck S; Hematology/Oncology Flow Cytometry Laboratory, Children's Hospital of Michigan, Carmen and Ann Adams Department of Pediatrics, Detroit, Michigan.
  • Gadgeel M; Blood and Marrow Transplant Program, Children's Hospital of Michigan, Carmen and Ann Adams Department of Pediatrics, Barbara Ann Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, Michigan.
  • Gabali A; Division of Hematology/Oncology, Carmen and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan.
Cytometry B Clin Cytom ; 94(3): 477-483, 2018 05.
Article em En | MEDLINE | ID: mdl-29244249
BACKGROUND: Flow cytometric intracellular myeloperoxidase (MPO) staining of leukemic blasts is a useful tool in diagnosis of leukemia subtype. Interpretation of high MPO-positivity can be a diagnostic challenge in B-lineage acute lymphoblastic leukemia (B-ALL). While very few such cases have been reported, high MPO positive B-ALL cases without additional myeloid antigen positivity are suspect and require further investigation. METHODS: Three pediatric cases of B-ALL with strong MPO staining (clone 8E6; Invitrogen) at diagnosis and three others with negative MPO staining were studied by flow cytometry and immunohistochemistry. In-vitro drug cytotoxicity, oxidative stress generation, and immunophenotyping using other MPO clones were performed to further investigate MPO presence. RESULTS: Expectedly, normal myeloid cells in all six samples were positive and mature lymphocytes negative for MPO staining. However, MPO monoclonal antibody (mAb) obtained from clones other than Invitrogen and other myeloid-specific mAbs gave negative results suggesting false positivity of the initial MPO staining. Immunohistochemistry for MPO was also negative on all six cases tested. Furthermore, in-vitro vincristine cytotoxicity was greater in leukemic cells from MPO false-positive cases compared with MPO-negative B-ALL samples, demonstrating indirect lack of MPO activity. Moreover, drug treatment did not lead to generation of reactive oxidative species, also reflective of lack of significant MPO presence. CONCLUSIONS: The cause of false-positive MPO staining remains unknown in these three cases; a cross reactivity could be the culprit. Caution should be given to similar phenomena and detailed investigation may contribute to the understanding of altered protein expression in such outlier cases. © 2017 International Clinical Cytometry Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peroxidase / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peroxidase / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos